Clinic
Louis H Mccormick MD, LLC
Louis H Mccormick MD, LLC was paid $531K by Medicaid between Jan 2018 and Dec 2024, across 25 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 67% of everything it billed.
33Billing provider infoLOUIS H MCCORMICK MD, LLC
FRANKLIN, LA 70538
FRANKLIN, LA 70538
33aNPI1154503241assigned 11/29/2007
33bProvider typeClinic/Center
28Total paid$531K
24GClaims16,318
24DCodes billed25
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Louisiana
Rank by total paid#42 of 112
Median peer was paid$138K
This provider vs. median3.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,870 | $101K | |
| 2019 | 2,614 | $82K | |
| 2020 | 1,872 | $62K | |
| 2021 | 2,200 | $77K | |
| 2022 | 2,850 | $93K | |
| 2023 | 2,552 | $77K | |
| 2024incomplete | 1,360 | $40K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 67% | 10,041 | 8,212 | $353K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 12% | 909 | 845 | $63K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.7% | 1,635 | 1,509 | $36K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.3% | 351 | 313 | $18K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.6% | 408 | 342 | $14K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.6% | 258 | 233 | $14K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.3% | 101 | 99 | $7K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.2% | 473 | 442 | $6K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 15 | 12 | $5K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 345 | 304 | $4K |
| 90688 | <1% | 265 | 255 | $4K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 54 | 53 | $3K |
13 more codes
| 90686 | <1% | 120 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 48 | $564.59 |
| 99441 | <1% | 854 | $528.62 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 84 | $382.99 |
| 81002 | <1% | 183 | $353.15 | |
| 0012A | <1% | 14 | $347.41 | |
| 0011A | <1% | 19 | $314.41 | |
| 90658 | <1% | 15 | $275.56 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 20 | $210.12 |
| 81025 | <1% | 31 | $157.75 | |
| 92551 | <1% | 13 | $105.83 | |
| 99173 | <1% | 12 | $23.32 | |
| 91301 | 0% | 50 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMCCORMICK, LOUIS (OWNER)